Clinical trial
GW572016 Combined With Trastuzumab For The Treatment Of Previously…
NCT00371488 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00371488 |
|---|---|
| Title | GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer |
| Official title | Phase I Study of Lapatinib in Combination With Trastuzumab |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms, Breast |
| Intervention type | Drug |
| Interventions | GW572016 oral tablets |
| Enrollment | 11 |
| Start date | Apr 6, 2006 |
| Primary completion | Dec 10, 2007 |
| Completion | Dec 10, 2007 |
| First posted | Sep 4, 2006 |
| Last update posted | Aug 31, 2018 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: